Cystic fibrosis

Clinics in Perinatology

Volumn 28, Issue 2, 2001, Pages 383-393

  Shulman, Lee P ^a   Elias, Sherman ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL FEATURE; CYSTIC FIBROSIS; FERTILITY; GENE MUTATION; GENETIC SCREENING; HETEROZYGOTE DETECTION; MOLECULAR GENETICS; PATHOPHYSIOLOGY; PREGNANCY; PRIORITY JOURNAL; REVIEW;

EID: 0034898051     PISSN: 00955108     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0095-5108(05)70090-7     Document Type: Article

References (52)

1. Screening for five mutations detects 97% of cystic fibrosis (CF) chromosomes and predicts a carrier frequency of 1:29 in the Jewish Ashkenazi population
2. Reporting the results of cystic fibrosis carrier screening
3. Predicting the risk of cystic fibrosis with echogenic bowel and one CF mutation
4. Mutations in the cystic fibrosis gene in patients with congenital absence of the vas deferens
5. Spectrum of CFTR mutations in cystic fibrosis and in congenital absence of the vas deferens in France
6. Relation between mutations of the cystic fibrosis gene and idiopathic pancreatitis
7. Frequent occurrence of the CFTR intron 8 (TG)n 5T allele in men with congenital bilateral absence of the vas deferens
8. A robotics-assisted procedure for large scale cystic fibrosis mutation analysis
9. Geographic distribution and regional origin of 272 cystic fibrosis mutations in European populations: The Biomed CF Mutation Analysis Consortium
10. Prenatal diagnosis of cystic fibrosis
11. Risk of cystic fibrosis with prenatally detected echogenic bowel
12. The changing epidemiology of cystic fibrosis
13. Pregnancy and cystic fibrosis: A case-controlled study
14. Hypofertility with thick cervical mucus: Another mild form of cystic fibrosis?
15. Genetic analysis of Hispanic individuals with cystic fibrosis
16. A multifunctional aqueous channel formed by CFTR
17. Female patients with cystic fibrosis suffer from reproductive endocrinological disorders despite good clinical status
18. Cystic fibrosis mutation screening in CBAVD patients and men with obstructive azoospermia or severe azoospermia
19. Cystic fibrosis in pregnancy
20. Identification of the cystic fibrosis gene: Genetic analysis
21. The relation between genotype and phenotype in cystic fibrosis: Analysis of the most common mutation (ΔF508)
22. Genetic determination of exocrine pancreatic function in cystic fibrosis
23. Cystic fibrosis: Gastrointestinal complications
24. Identification of common cystic fibrosis mutations in African-Americans with cystic fibrosis increases the detection rate to 75%
25. Sensitivity of the denaturing gradient gel electrophoresis technique in detection of known mutations and novel Asian mutations in the CFTR gene
26. Screening for cystic fibrosis carrier state
27. Is congenital bilateral absence of vas deferens a primary form of cystic fibrosis? Analyses of the CFTR gene in 67 patients
28. Genotype-phenotype relationships in cystic fibrosis
29. The risk of cystic fibrosis with prenatally detected echogenic bowel in an ethnically and racially diverse North American population
30. Mutation analysis of the cystic fibrosis and cationic trypsinogen genes in patients with alcohol-related pancreatitis
31. Diagnosis, screening and management of cystic fibrosis related diabetes mellitus: A consensus conference report
32. Cystic fibrosis screening: A fetus with hyperechogenic bowel may be an index
33. National Institutes of Health Consensus Development Conference Statement on genetic testing for cystic fibrosis: Genetic testing for cystic fibrosis
34. The genetics of male reproduction
35. Managing infertility due to absence of the vas deferens
36. The genetic basis of congenital bilateral absence of the vas deferens and cystic fibrosis
37. Microscopic epididymal sperm aspiration (MESA): A new option for treatment of the obstructive azoospermia associated with cystic fibrosis
38. Cystic fibrosis mutations among African Americans in the southeastern United States
39. Contraception and genetic disorders
40. Role of the cystic fibrosis transmembrane conductance regulator in innate immunity to Pseudomonas aeruginosa infections
41. Identification of the cystic fibrosis gene: Cloning and characterization of complementary DNA
42. Reproductive and sexual health in adolescents with cystic fibrosis
43. Association of the nonsense mutation (W1282X), the most common mutation in the Ashkenazi Jewish cystic fibrosis patients in Israel, with presentation of severe disease
44. Conventional in-vitro fertilization versus intracytoplasmic sperm injection for patients requiring microsurgical sperm aspiration
45. Statement of the American Society of Human Genetics on cystic fibrosis screening
46. The diagnosis of cystic fibrosis
47. The spectrum of cystic fibrosis mutations
48. The cystic fibrosis transmembrane conductance regulator gene
49. Cystic fibrosis locus defined by a genetically linked polymorphic DNA marker
50. Couple screening for cystic fibrosis
51. Genotypes of cystic fibrosis (CF) in the world and polymorphisms of cystic fibrosis transmembrane regulator (CFTR) gene in Japan
52. Genomic sequence of the cystic fibrosis conductance regulator (CFTR) gene